Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V St Georgiev

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro activity of novel 5-carbonyl derivatives of 3-phenyl-3-(1H-imidazol-1-ylmethyl)- 2-methyl-isoxazolidinesG A Bennett, G B Mullen, T R DeCory, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro antifungal activity of novel substituted 3,5-diphenyl-3-(1H-1,2,4-triazol-1-ylmethyl)-2- methylisoxazolidine derivativesG A Bennett, P A Swift, G B Mullen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Synthesis and antifungal activity of novel isoxazolidine compoundsG B Mullen, P A Swift, G A Bennett, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Substituted 5-phenoxyalkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidines. Antifungal activity and structure-activity relationship studiesG B Mullen, D M Maryniak, P A Swift, et al.
Annals of the New York Academy of Sciences|January 1, 1988
cis-3-(substituted phenyl)-3-(1H-imidazol-1-ylmethyl)-2-methyl-5-([(substituted phenyl)thio(or amino)]methyl)isoxazolidines. In vitro antifungal activity and structure-activity relationshipsT R DeCory, P A Swift, G B Mullen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
3-(substituted phenyl)-3-(1H-1,2,4-triazol-1-ylmethyl)-2-methyl-5- [(substituted phenoxy)methyl]-isoxazolidine derivatives. Structure-activity relationshipsG A Bennett, P A Swift, G B Mullen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
cis-5-alkyl(or alkenyl)-3-phenyl-3-(1H-imidazole-1-ylmethyl)-2- methylisoxazolidine derivatives. In vitro antifungal activity and structure-activity relationshipsP A Swift, G A Bennett, G B Mullen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Comparisons of ketoconazole, PR 969-566, PR 967-234, and PR 967-248 as antifungals in vitro and in the rat model of candidal vaginitis based on efficacy/safety profilesG C Palmer, J M Ordy, R D Simmons, et al.
Archiv Der Pharmazie|September 1, 1989
Antifungal activity of novel 5-carbonyl derivatives of 3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidinesG A Bennett, G B Mullen, T R DeCory, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1989
Selection of orally active antifungal agents from 3,5-substituted isoxazolidine derivatives based on acute efficacy-safety profilesG C Palmer, M J Ordy, R D Simmons, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro activity of novel 5-carbonyl derivatives of 3-phenyl-3-(1H-imidazol-1-ylmethyl)- 2-methyl-isoxazolidinesG A Bennett, G B Mullen, T R DeCory, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro antifungal activity of novel substituted 3,5-diphenyl-3-(1H-1,2,4-triazol-1-ylmethyl)-2- methylisoxazolidine derivativesG A Bennett, P A Swift, G B Mullen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Synthesis and antifungal activity of novel isoxazolidine compoundsG B Mullen, P A Swift, G A Bennett, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Substituted 5-phenoxyalkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidines. Antifungal activity and structure-activity relationship studiesG B Mullen, D M Maryniak, P A Swift, et al.
Annals of the New York Academy of Sciences|January 1, 1988
cis-3-(substituted phenyl)-3-(1H-imidazol-1-ylmethyl)-2-methyl-5-([(substituted phenyl)thio(or amino)]methyl)isoxazolidines. In vitro antifungal activity and structure-activity relationshipsT R DeCory, P A Swift, G B Mullen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
3-(substituted phenyl)-3-(1H-1,2,4-triazol-1-ylmethyl)-2-methyl-5- [(substituted phenoxy)methyl]-isoxazolidine derivatives. Structure-activity relationshipsG A Bennett, P A Swift, G B Mullen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
cis-5-alkyl(or alkenyl)-3-phenyl-3-(1H-imidazole-1-ylmethyl)-2- methylisoxazolidine derivatives. In vitro antifungal activity and structure-activity relationshipsP A Swift, G A Bennett, G B Mullen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Comparisons of ketoconazole, PR 969-566, PR 967-234, and PR 967-248 as antifungals in vitro and in the rat model of candidal vaginitis based on efficacy/safety profilesG C Palmer, J M Ordy, R D Simmons, et al.
Archiv Der Pharmazie|September 1, 1989
Antifungal activity of novel 5-carbonyl derivatives of 3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidinesG A Bennett, G B Mullen, T R DeCory, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1989
Selection of orally active antifungal agents from 3,5-substituted isoxazolidine derivatives based on acute efficacy-safety profilesG C Palmer, M J Ordy, R D Simmons, et al.
Pageof 4